23.51
0.21%
0.05
시간 외 거래:
23.40
-0.11
-0.47%
전일 마감가:
$23.46
열려 있는:
$23.49
하루 거래량:
146.58K
Relative Volume:
0.51
시가총액:
$1.64B
수익:
$26.98M
순이익/손실:
$-180.66M
주가수익비율:
-5.0235
EPS:
-4.68
순현금흐름:
$-63.56M
1주 성능:
-3.92%
1개월 성능:
-0.38%
6개월 성능:
-4.35%
1년 성능:
+51.38%
Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile
명칭
Bicycle Therapeutics Plc Adr
전화
011441223261503
주소
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE
Bicycle Therapeutics Plc Adr Stock (BCYC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-09-11 | 업그레이드 | B. Riley Securities | Neutral → Buy |
2022-08-31 | 개시 | Cowen | Outperform |
2022-07-28 | 개시 | Barclays | Overweight |
2022-07-06 | 재개 | Canaccord Genuity | Buy |
2022-04-13 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
2022-04-07 | 재개 | Cantor Fitzgerald | Overweight |
2022-02-14 | 개시 | Morgan Stanley | Equal-Weight |
2021-12-17 | 개시 | SVB Leerink | Outperform |
2021-12-09 | 개시 | Needham | Buy |
2021-09-30 | 개시 | B. Riley Securities | Buy |
2021-04-20 | 개시 | JMP Securities | Mkt Outperform |
2020-10-12 | 개시 | Cantor Fitzgerald | Overweight |
2020-06-12 | 개시 | Oppenheimer | Outperform |
2020-04-17 | 개시 | H.C. Wainwright | Buy |
2019-11-14 | 개시 | ROTH Capital | Buy |
2019-09-11 | 업그레이드 | Goldman | Neutral → Buy |
2019-06-17 | 개시 | Canaccord Genuity | Buy |
2019-06-17 | 개시 | Goldman | Neutral |
2019-06-17 | 개시 | Jefferies | Buy |
2019-06-17 | 개시 | Piper Jaffray | Overweight |
모두보기
Bicycle Therapeutics Plc Adr 주식(BCYC)의 최신 뉴스
Bicycle Therapeutics' SWOT analysis: stock's potential rides on innovative platform - Investing.com India
Bicycle Therapeutics spotlights cancer treatment targets - Investing.com
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - MSN
A company insider recently sold 3,212 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You also Consider to Sale? – Knox Daily - Knox Daily
BCYC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC)’s stock price range in the last year - US Post News
Bicycle therapeutics executive sells shares worth over $21k - Investing.com India
Bicycle therapeutics executive sells shares to cover tax obligations - Investing.com India
Bicycle therapeutics COO sells shares worth over $21k - Investing.com India
Bicycle therapeutics CEO sells shares worth over $71k - Investing.com
Bicycle therapeutics CTO sells shares worth over $21k - Investing.com
Bicycle therapeutics executive sells shares worth over $5,000 - Investing.com
CHIEF PROD & SUPPLY CHAIN OFF Hannay Michael Charles Ferguso sale 246 shares of Bicycle Therapeutics Plc ADR [BCYC] – Knox Daily - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC)’s stock chart: A technical perspective - US Post News
Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 22.56 - The Dwinnex
Wall Street SWOT: Bicycle Therapeutics stock rides high on cancer drug promise - Investing.com
A company insider recently sold 246 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You Sale? - Knox Daily
Nothing is Better Than Bicycle Therapeutics Plc ADR (BCYC) stock at the moment - SETE News
RBC Capital Mkts initates Bicycle Therapeutics Plc ADR (BCYC) stock to an Outperform - Knox Daily
Metric Analysis: Bicycle Therapeutics Plc ADR (BCYC)’s Key Ratios in the Limelight - The Dwinnex
Bicycle Therapeutics Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Are Bicycle Therapeutics Plc ADR (BCYC) shares a good deal now? - US Post News
Hain Celestial Group Inc [HAIN] Investment Guide: What You Need to Know - Knox Daily
Bicycle Therapeutics stock maintains Buy rating post-ESMO data By Investing.com - Investing.com UK
Bicycle Therapeutics Plc ADR [BCYC] Shares Fall -0.26 % on Wednesday - Knox Daily
A stock that deserves closer examination: Bicycle Therapeutics Plc ADR (BCYC) - US Post News
Bicycle Therapeutics Plc ADR (BCYC) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Aqua Metals Inc [AQMS] Shares Fall Approximately -81.89% Over the Year - Knox Daily
Taking a look at what insiders are doing to gauge the Interface Inc. [TILE] - Knox Daily
Sleep Number Corp [SNBR] Director makes an insider purchase of 43,000 shares worth 0.53 million. - Knox Daily
Top investors say Bicycle Therapeutics Plc ADR (BCYC) ticks everything they need - SETE News
Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade - MSN
An Analysis of Bicycle Therapeutics Plc ADR (BCYC)’s Potential Price Growth - Knox Daily
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 - MSN
What Makes Bicycle Therapeutics (BCYC) a New Buy Stock - Yahoo Finance
Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High? - Yahoo Finance
B. Riley Securities’s latest rating for BCYC stock - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC) may enjoy gains as insiders got busy in the recent days - Knox Daily
Bicycle Therapeutics Plc ADR’s latest rating changes from various analysts - Knox Daily
Bicycle Therapeutics Plc ADR [BCYC] Investment Appeal on the Rise – Knox Daily - Knox Daily
Is it a good time to sell Wendy's Co [WEN] shares after an insider sold 21000 shares? – Knox Daily - Knox Daily
Strength Seen in Bicycle Therapeutics PLC Sponsored ADR (BCYC): Can Its 5.9% Jump Turn into More Strength? - Yahoo Movies UK
Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up - Yahoo News Malaysia
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Soars 19.3%: Is Further Upside Left in the Stock? - Yahoo Sport Australia
Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year? - Yahoo Finance
Investing in Bicycle Therapeutics Plc ADR (BCYC) Is Getting More Attractive – Knox Daily - Knox Daily
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research
Trading Day Review: Bicycle Therapeutics Plc ADR (BCYC) Loses Momentum, Closing at 20.75 – DWinneX - The Dwinnex
BCYC Stock on the Rise: A Promising Investment - The InvestChronicle
Bicycle Therapeutics Plc Adr (BCYC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bicycle Therapeutics Plc Adr 주식 (BCYC) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Hannay Michael Charles Ferguso | CHIEF PROD & SUPPLY CHAIN OFF |
Oct 03 '24 |
Sale |
22.26 |
247 |
5,498 |
22,398 |
Skynner Michael | CHIEF TECHNOLOGY OFFICER |
Oct 03 '24 |
Sale |
22.26 |
972 |
21,637 |
92,945 |
Milnes Alistair | CHIEF OPERATING OFFICER |
Oct 03 '24 |
Sale |
22.26 |
972 |
21,637 |
70,302 |
Crockett Nigel | CHIEF BUSINESS OFFICER |
Oct 03 '24 |
Sale |
22.26 |
972 |
21,637 |
45,822 |
Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER |
Oct 03 '24 |
Sale |
22.26 |
153 |
3,406 |
22,922 |
자본화:
|
볼륨(24시간):